Pharmacodynamic profile in East Asian patients with ACS treated with prasugrel standard-dose v de-escalation strategy: a randomized A-MATCH trial.

Abstract:

:Compared with Caucasian patients, East Asian patients have the unique risk-benefit trade-off and different responsiveness to antithrombotic regimens. The aim of this study was to compare pharmacodynamic profile in East Asian patients with acute coronary syndromes (ACS) treated with prasugrel standard-dose vs. de-escalation strategy. Before discharge, ACS patients with age <75 year or weight ≥60 kg (n=250) were randomly assigned to the standard-dose (10-mg group) or de-escalation strategy (5-mg group or platelet function test [PFT]-guided group). After 1 month, VerifyNow P2Y12 assay-based platelet reactivity (P2Y12 Reaction Units [PRU]) and bleeding episodes were evaluated. Primary endpoint was the percentage of patients with the therapeutic window (85≤PRU≤208). The percentage of patients within the therapeutic window was significantly lower in the 10-mg group compared to the 5-mg and PFT-guided groups (35.3% vs. 67.5% vs. 65.9%) (Odds ratio [OR], 3.80 and 3.54; 95% confidence interval [CI], 2.01-7.21 and 1.87-6.69, respectively). Compared with the 10-mg group, the bleeding rate was tended to be lower with de-escalation strategies (35.3% vs. 24.1% vs. 23.2%) (Hazard ratio [HR], 0.58 and 0.55; 95% CI, 0.30-1.14 and 0.28-1.09, respectively). 'PRU<127' was the optimal cut-off for predicting one-month bleeding events (area under curve, 0.616; 95% CI, 0.543-0.689; p= 0.005), which criteria was significantly associated with early discontinuation of prasugrel treatment (HR, 2.00; 95% CI, 1.28-3.03; p= 0.001). In conclusion, compared with the standard-dose prasugrel, prasugrel de-escalation strategy in East Asian patients presented with ACS showed a higher chance within the therapeutic window and a lower tendency toward bleeding episodes.

journal_name

Thromb Haemost

authors

Jeong YH,Oh JH,Yoon HJ,Park Y,Suh J,Lee SW,Lee K,Kim JS,Chun WJ,Park YH,Nam CW,Kim JH,Ahn JH,Hwang SJ,Hwang JY,Tantry US,Gurbel P,Shin ES

doi

10.1055/a-1346-3300

subject

Has Abstract

pub_date

2021-01-05 00:00:00

eissn

0340-6245

issn

2567-689X

pub_type

临床试验
  • Increased platelet activation in young Zucker rats with impaired glucose tolerance is improved by acarbose.

    abstract::Patients with diabetes display increased platelet activation. Recent data show a markedly increased risk for cardiovascular events already in pre-diabetic individuals with impaired glucose tolerance (IGT). We investigated whether IGT is associated with platelet activation. Blood samples were collected from young lean ...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:10.1160/TH04-02-0118

    authors: Schäfer A,Widder J,Eigenthaler M,Bischoff H,Ertl G,Bauersachs J

    更新日期:2004-07-01 00:00:00

  • Complete covalent structure of human platelet factor 4.

    abstract::The amino acid sequence of the subunit of human platelet factor 4 has been determined. Human platelet factor 4 consists of identical subunits containing 70 amino acids, each with a molecular weight of 7,756. The molecule contains no methionine, phenylalanine or tryptophan. The proposed amino acid sequence of PF4 is: G...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Morgan FJ,Begg GS,Chesterman CN

    更新日期:1980-02-29 00:00:00

  • A 23bp insertion in the endothelial protein C receptor (EPCR) gene impairs EPCR function.

    abstract::EPCR is a type I transmembrane protein, highly expressed on the endothelium of large vessels, that binds protein C and augments its activation. In this study, a 23bp insertion in the EPCR gene was found in 4/198 survivors of myocardial infarction and 3/194 patients with deep vein thrombosis. The EPCR gene with the ins...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Biguzzi E,Merati G,Liaw PC,Bucciarelli P,Oganesyan N,Qu D,Gu JM,Fetiveau R,Esmon CT,Mannucci PM,Faioni EM

    更新日期:2001-10-01 00:00:00

  • Sulfated, low-molecular-weight lignins are potent inhibitorsof plasmin, in addition to thrombin and factor Xa: Novel opportunity for controlling complex pathologies.

    abstract::Recently we prepared sulfated, low-molecular-weight lignins (LMWLs) to mimic the biological activities of heparin and heparan sulfate. Chemo-enzymatically prepared sulfated LMWLs represent a library of diverse non-sugar, aromatic molecules with structures radically different from the heparins, and have been found to p...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:10.1160/TH09-07-0454

    authors: Henry BL,Abdel Aziz M,Zhou Q,Desai UR

    更新日期:2010-03-01 00:00:00

  • Fibrotic injury after experimental deep vein thrombosis is determined by the mechanism of thrombogenesis.

    abstract::Vessel wall matrix changes occur after injury, although this has not been well studied in the venous system. This study tested the hypothesis that the thrombus dictates the vein wall response and vein wall damage is directly related to the duration of thrombus contact. To determine the injury response over time, rats ...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Henke PK,Varma MR,Moaveni DK,Dewyer NA,Moore AJ,Lynch EM,Longo C,Deatrick CB,Kunkel SL,Upchurch GR Jr,Wakefield TW

    更新日期:2007-11-01 00:00:00

  • Collagen or collagen-related peptide cause (Ca2+)i elevation and increased tyrosine phosphorylation in human megakaryocytes.

    abstract::Since megakaryocytes are the cellular precursors of platelets we have investigated whether they share responses to platelet agonists, in particular collagen. Although previous studies have reported responses to thrombin in non-human megakaryocytes, through studies of single cell calcium responses and protein tyrosine-...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Mountford JC,Melford SK,Bunce CM,Gibbins J,Watson SP

    更新日期:1999-09-01 00:00:00

  • Procoagulant properties of intravenous staphylokinase versus tissue-type plasminogen activator.

    abstract::The fibrin-specificity and procoagulant effects of recombinant staphylokinase (Sak42D) were compared with those of recombinant tissue-type plasminogen activator (rt-PA) in patients with acute myocardial infarction. Plasma samples were obtained at baseline and at 25 and 90 min, from 24 patients who were randomly assign...

    journal_title:Thrombosis and haemostasis

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Okada K,Lijnen HR,Moreau H,Vanderschueren S,Collen D

    更新日期:1996-12-01 00:00:00

  • Anti-beta2 glycoprotein I antibodies and platelet activation in patients with antiphospholipid antibodies: association with increased excretion of platelet-derived thromboxane urinary metabolites.

    abstract::Platelet activation may contribute to the increased risk of thrombotic complications in patients with antiphospholipid antibodies (aPL). The increased urinary excretion of 11-dehydro-thromboxane B2 (11-DH-TXB2) reported in patients with lupus anticoagulant (LA) and/or anticardiolipin antibodies (aCL) reflects in vivo ...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Forastiero R,Martinuzzo M,Carreras LO,Maclouf J

    更新日期:1998-01-01 00:00:00

  • The role of the factor X activation peptide: a deletion mutagenesis approach.

    abstract::To understand the role of the factor X (fX) activation peptide (AP), a deletion mutagenesis approach was employed. Two single-chain, variant enzymes were generated in which 41 residues were deleted from the AP: fX (des-137-183) and fX(des-137-183;N191A), which lacks a carbohydrate moiety at Asn191 due to an alanine su...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Rudolph AE,Mullane MP,Porche-Sorbet R,Daust HA,Miletich JP

    更新日期:2002-11-01 00:00:00

  • Measurement of soluble fibrin monomer-fibrinogen complex in plasmas derived from patients with various underlying clinical situations.

    abstract::We previously reported a monoclonal antibody named IF-43 that specifically recognizes thrombin-modified fibrinogen (desAA- and desAABB- fibrin monomer) bound with fibrinogen or other D(1) domain-containing plasmic fragments such as fragments X,Y, and D(1), but not intact fibrinogen or cross-linked fibrin degradation p...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Nakahara K,Kazahaya Y,Shintani Y,Yamazumi K,Eguchi Y,Koga S,Wada H,Matsuda M

    更新日期:2003-05-01 00:00:00

  • Factor VIIa in patients with C1-inhibitor deficiency.

    abstract::In hereditary angioedema (HAE), normal C1-inhibitor (C1-INH) is low and the contact system activated. Recently, the findings of a tissue factor mutant selectively deficient in promoting the conversion of FVII to FVIIa, but with retained cofactor for FVIIa, made it possible to examine reliably the pre-existing content ...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Nielsen EW,Morrissey J,Olsen JO,Osterud B

    更新日期:1995-10-01 00:00:00

  • Venous thromboembolism in critically ill patients. Observations from a randomized trial in sepsis.

    abstract::Venous thromboembolism (VTE) is a central concern in the intensive care unit (ICU). However, little is known about both current practices for VTE prevention in the ICU and the risk for VTE in persons with severe sepsis and septic shock. XPRESS was a randomized, double-blind, placebo-controlled trial of prophylactic he...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章,随机对照试验

    doi:

    authors: Shorr AF,Williams MD

    更新日期:2009-01-01 00:00:00

  • The epidermal growth factor receptor (EGFR) and proline rich tyrosine kinase 2 (PYK2) are involved in tissue factor dependent factor VIIa signalling in HaCaT cells.

    abstract::Binding of the coagulation protease factor VIIa to its receptor Tissue Factor (TF) induces intracellular signals in several cell types including HaCaT keratinocytes. TF belongs to the cytokine receptor family, but is most likely not alone in transferring the complete TF/FVIIa signal over the plasma membrane. The prote...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:10.1160/TH03-08-0549

    authors: Wiiger MT,Prydz H

    更新日期:2004-07-01 00:00:00

  • Characterization of the binding of bovine thrombin to isolated rat hepatocytes.

    abstract::Isolated rat hepatocytes possess per cell 4,500 high-affinity binding sites for thrombin with a Kd of 30-40 pM, and 2.8 X 10(5) low-affinity sites with a Kd of 30 nM. These binding sites are highly specific for thrombin. Half-maximal binding of 125I-labelled thrombin is achieved after 3 min at 37 degrees C and 7 min a...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Weyer B,Petersen TE,Sonne O

    更新日期:1988-12-22 00:00:00

  • Inhibition of platelet thrombosis using an activated protein C-loaded stent: in vitro and in vivo results.

    abstract::In high-risk and complicated coronary intervention, the risk of acute closure is unpredictable. Thrombus and platelet deposition at the intervention site may also have further effects on subsequent restenosis. In vivo infusion of activated protein C has previously been shown to achieve potent anticoagulation without a...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Foo RS,Gershlick AH,Hogrefe K,Baron JH,Johnston TW,Hussey AJ,Garner I,de Bono DP

    更新日期:2000-03-01 00:00:00

  • Purification and properties of prothrombin modified by asbestos filtration of human plasma.

    abstract::Filtration through asbestos filter (Seitz) of human plasma modified the prothrombin molecule as previously shown. Factor II could no longer be activated by physiological activators (Ca++ + phospholipid + V and Xa) but reacted readily with staphylocoagulase. The separation and purification of the modified prothrombin a...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Izuchi Y,Boffa MC,Soulier JP

    更新日期:1979-02-15 00:00:00

  • Effect of altitude on thrombopoietin and the platelet count in healthy volunteers.

    abstract::Although there is evidence that altitude increases the platelet count, its effect on the platelet precursor stimulating factor, thrombopoietin (TPO), is unclear. Unlike erythropoietin, TPO appears largely unresponsive to exogenous signals. In a study in 16 healthy volunteers, we report the effects of altitude exposure...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:10.1160/TH04-02-0086

    authors: Hartmann S,Krafft A,Huch R,Breymann C

    更新日期:2005-01-01 00:00:00

  • Protective effect of ischaemic preconditioning on ischaemia/reperfusion-induced microvascular obstruction determined by on-line measurements of coronary pressure and blood flow in pigs.

    abstract::We investigated the protective effect of ischaemic preconditioning (IP) on the maintenance of coronary patency using on-line measurements of coronary pressures and blood flow in a closed-chest reperfused acute myocardial infarction (MI) model in pigs. Catheter-based 90-min occlusion followed by 60-min reperfusion of t...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:10.1160/TH09-03-0165

    authors: Posa A,Pavo N,Hemetsberger R,Csonka C,Csont T,Ferdinandy P,Petrási Z,Varga C,Pavo IJ,Laszlo F Jr,Huber K,Gyöngyösi M

    更新日期:2010-02-01 00:00:00

  • A randomized and blinded comparison of three bleeding time techniques: the Ivy method, and the Simplate II method in two directions.

    abstract::We compared the Ivy bleeding time method and two alternatives of the Simplate II method (incisions in horizontal and vertical direction) with each other, with regard to the sensitivity, the specificity, the costs and the burden for the patient. In the aspirin study an aspirin-induced bleeding defect was used. Seventy-...

    journal_title:Thrombosis and haemostasis

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Srámek R,Srámek A,Koster T,Briët E,Rosendaal FR

    更新日期:1992-05-04 00:00:00

  • Intraoperative fresh-frozen plasma versus human albumin in craniofacial surgery--a pilot study comparing coagulation profiles in infants younger than 12 months.

    abstract::The transfusion of fresh-frozen plasma (FFP) is suggested to minimize dilution coagulopathy when applied instead of colloids during paediatric craniofacial surgery (pCFS). We prospectively compared plasmatic haemostaseologic function between volume replacement with FFPs versus human albumin (HA) in a pilot study. Thir...

    journal_title:Thrombosis and haemostasis

    pub_type: 临床试验,杂志文章

    doi:

    authors: Hildebrandt B,Machotta A,Riess H,Kerner S,Ahlers O,Haberl H,Dörken B,Kerner T

    更新日期:2007-07-01 00:00:00

  • First case of sporadic protein S deficiency due to a novel candidate mutation, Ala 484-->Pro, in the protein S active gene (PROS1).

    abstract::In a series of 16 propositi with symptomatic protein S deficiency and a protein S gene mutation, we identified a sporadic case of a novel mutation that probably affects gene expression. The mutation, a G to C transversion leading to the substitution of Ala 484 by Pro, was not found in the protein S gene of the patient...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Borgel D,Jude B,Aiach M,Gandrille S

    更新日期:1996-06-01 00:00:00

  • Characterization of the anticoagulant activities from a Brazilian arrow poison.

    abstract::A recent report indicated that an arrow poison used by the native Indians of Rondonia, Brazil, to kill small animals was associated with profuse bleeding. The arrow poison was prepared from the bark of a tree, known locally as Tike-Uba. We have obtained bark and sap specimens from this tree and have characterized a po...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Jacobs JW,Petroski C,Friedman PA,Simpson E

    更新日期:1990-02-19 00:00:00

  • von Willebrand factor multimer patterns in pregnancy-induced hypertension.

    abstract::Microangiopathy and disseminated platelet aggregation have been reported in thrombotic thrombocytopenic purpura (TTP) and pregnancy-induced hypertension (PIH). Since unusually large von Willebrand factor (vWF) multimers have been implicated in the evolvement of TTP, we analyzed factor VIII/vWF parameters in patients w...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Brenner B,Zwang E,Bronshtein M,Seligsohn U

    更新日期:1989-09-29 00:00:00

  • Recombinant human activated factor VII is thrombogenic in a rabbit model of cyclic flow reduction and does not reduce intra-abdominal bleeding.

    abstract::Recombinant human activated factor VII (rHuFVIIa) can reduce bleeding but may be associated with arterial thrombosis. We hypothesized that rHuFVIIa would increase the occurrence of cyclic flow reductions (CFR) and reduce intra-abdominal bleeding in an experimental model. An adapted Folts' model of carotid artery lesio...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Charbonneau S,Girard F,Boudreault D,Ruel M,Blais N,Hardy JF

    更新日期:2007-02-01 00:00:00

  • Aggregation of human platelets by acidic mucopolysaccharide extracted from Stichopus japonicus Selenka.

    abstract::The acidic mucopolysaccharide extracted from sea cucumber (Stichopus japonicus Selenka) (SJAMP) has been shown to cause platelets to aggregate. Using citrated platelet-rich plasma (PRP), washed platelets and formaldehyde-fixed platelets from humans, we investigated the effects of platelet inhibitors and various plasma...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Li JZ,Lian EC

    更新日期:1988-06-16 00:00:00

  • Tissue factor, protease activated receptors and pathologic heart remodelling.

    abstract::Tissue factor is the primary initiator of coagulation cascade and plays an essential role in haemostasis and thrombosis. In addition, tissue factor and coagulation proteases contribute to many cellular responses via activation of protease activated receptors. The heart is an organ with high levels of constitutive tiss...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章,评审

    doi:10.1160/TH14-03-0243

    authors: Antoniak S,Sparkenbaugh E,Pawlinski R

    更新日期:2014-11-01 00:00:00

  • Effects of second and third generation oral contraceptives and their respective progestagens on the coagulation system in the absence or presence of the factor V Leiden mutation.

    abstract::Compared to second generation, the use of third generation oral contraceptives has been associated with an increased risk of venous thrombosis especially in women with the factor V Leiden mutation. To find an explanation for these risk differences we investigated the effects of desogestrel- and levonorgestrel-containi...

    journal_title:Thrombosis and haemostasis

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Kemmeren JM,Algra A,Meijers JC,Bouma BN,Grobbee DE

    更新日期:2002-02-01 00:00:00

  • Plasma carboxypeptidase U (CPU, CPB2, TAFIa) generation during in vitro clot lysis and its interplay between coagulation and fibrinolysis.

    abstract::Carboxypeptidase U (CPU, CPB2, TAFIa) is a basic carboxypeptidase that is able to attenuate fibrinolysis. The inactive precursor procarboxypeptidase U is converted to its active form by thrombin, the thrombin-thrombomodulin complex or plasmin. The aim of this study was to investigate and characterise the time course o...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:10.1160/TH17-02-0097

    authors: Leenaerts D,Aernouts J,Van Der Veken P,Sim Y,Lambeir AM,Hendriks D

    更新日期:2017-07-26 00:00:00

  • Pregnancy outcome of first trimester exposure to the vitamin K antagonist phenprocoumon depends on duration of treatment.

    abstract::The aim of this observational cohort study was to specify the risk of the vitamin K antagonist (VKA) phenprocoumon during first trimester of pregnancy, in particular to estimate the risk of birth defects and spontaneous fetal loss. Four hundred eight pregnancies with phenprocoumon exposure were compared to 1,642 pregn...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:10.1160/TH16-11-0838

    authors: Hüttel E,Padberg S,Meister R,Beck E,Schaefer C

    更新日期:2017-05-03 00:00:00

  • The second laminin G-type domain of protein S is indispensable for expression of full cofactor activity in activated protein C-catalysed inactivation of factor Va and factor VIIIa.

    abstract::Vitamin K-dependent protein S is a cofactor to the anticoagulant serine protease activated protein C (APC) in the proteolytic inactivation of the procoagulant, activated factor V (FVa) and factor VIII (FVIIIa). In the FVa degradation, protein S selectively accelerates the cleavage at Arg306, having no effect on the Ar...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Evenäs P,García de Frutos P,Nicolaes GA,Dahlbäck B

    更新日期:2000-08-01 00:00:00